|
Website:
http://www.biogen.com
Phone: +1 617 679-2000 |
Address:
14 Cambridge Center
Cambridge, MASSACHUSETTS 02142 |
Company Description
Biogen, Inc.. The Group's principal activity is to develop, manufacture and market novel human therapeutic products. The Group currently sells AVONEX (r) for the treatment of relapsing multiple sclerosis (MS) and commencing in 2003, AMEVIVE (r) for the treatment of adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy. It also has a significant number of ongoing research programs. The products of the Group are marketed in the United States, Europe, Asia and other foreign countries. Vaccines and diagnostic products accounted for 90% of 2002 revenues and Royalties, 10%
Key People
| Chairman, President & Chief Executive | James C. Mullen |
| Executive Vice President Finance & Chief Financial Officer | Peter N. Kellogg |
| Executive Vice President, Secretary & General Counsel | Thomas J. Bucknum |
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
B
Biogen
Biotechnology company. Pioneering research by Biogen scientists has led to the development of several important new medical therapies.
www.biogen.com
Biotechnology company. Pioneering research by Biogen scientists has led to the development of several important new medical therapies.
www.biogen.com
Breaking News
Reuters India - November 25, 2009 3:35 PM
BOSTON (Reuters) - Rituxan, a drug used to treat cancer and rheumatoid arthritis, may help slow the development of newly discovered type 1 or juvenile diabetes, researchers reported on Wednesday. The drug may interfere with the body's mistaken ...
Reuters - November 25, 2009 3:11 PM
By Gene Emery BOSTON (Reuters) - Rituxan, a drug used to treat cancer and rheumatoid arthritis, may help slow the development of newly discovered type 1 or juvenile diabetes, researchers reported on Wednesday. The drug may interfere with the body's ...
Reuters UK - November 25, 2009 2:47 PM
* Rituxan stops immune cells that destroy healthy tissue * Single dose slowed development of diabetes * Multiple doses may be required BOSTON, Nov 25 (Reuters) - Rituxan, a drug used to treat cancer and rheumatoid arthritis, may help slow the development ...
Reuters - November 24, 2009 2:03 PM
CAMBRIDGE, Mass.--(Business Wire)-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Piper Jaffray 21st Annual Health Care Conference on Wednesday, ...
Reuters - November 23, 2009 5:45 AM
Experienced Drug Hunters Armed with Structure-Based G Protein-Coupled Receptor (GPCR) Drug Discovery Technology From The Scripps Research Institute SAN DIEGO--(Business Wire)-- Receptos, Inc., a privately held biopharmaceutical company, announced the ...
More BIOGEN INCORPORATED News
Biotech Incorporated Info
Get Info On Biotech Incorporated Access 10 Search Engines At Once.
www.Info.com/BiotechIncorporated
Get Info On Biotech Incorporated Access 10 Search Engines At Once.
www.Info.com/BiotechIncorporated
BioVendor biotechnology
Biotechnology company producing research and diagnostic products.
BioVendor.com
Biotechnology company producing research and diagnostic products.
BioVendor.com
